Amazon has made The Cancer Genome Atlas and The International Cancer Genome Consortium PanCancer data sets freely available through its cloud platform. The addition of the data sets continues Amazon's push to differentiate its cloud offering through the availability of data.
Illumina is to make a 5,000-genome autism database available through BaseSpace. The deal will enable researchers to analyze the genomes of people with autism and their families using tools built into Illumina's cloud computing platform.
Microsoft has captured a little corner of the market for cloud genomics infrastructure. The deal sees the IT giant make its Azure cloud computing platform available to UC Santa Cruz Genomics, which plans to use the system to support its work on the Human Genome Variation Map and other initiatives.
Intel has unveiled its pitch to become the organization that pulls cancer data out of silos. The semiconductor giant has spent the past two years working on the problem with Oregon Health & Science University, bringing it to the point at which it is ready to open up the platform to other organizations.
BioClinica has expanded the range of ways customers can access its suite of eClinical tools. The new service, dubbed the BioClinica eHealth Cloud, allows biopharma companies and CROs to run Express EDC, Trident RTSM and other pieces of trial software on public, private, managed or custom cloud infrastructure.
The battlefront between Amazon and Google covers a diverse range of fields, from online search and advertising, to smartphones and shopping. Increasingly, genomics is emerging as another hotspot, with both companies scrambling to establish themselves as the place to store and analyze DNA data.
Agilent Technologies has struck a deal to acquire Cartagenia. The buyout will give Agilent software to interpret clinical genomics data, an asset it plans to offer to its molecular oncology customers.
Medidata has connected its Clinical Cloud to Apple's ResearchKit. The link means researchers can feed data gathered by ResearchKit apps into Medidata's cloud platform, where the information can be integrated with other sources of clinical trial results.
AstraZeneca is extending its use of Elixir Software's R&D workflow-management software, in part to support communication while it is moving its focal point in the United Kingdom from Alderley Park to Cambridge.
Box has added a big-name client just days after pulling off a $175 million IPO. The deal sees AstraZeneca join Allergan and Eli Lilly on the list of major biopharma companies that use Box's cloud content sharing and collaboration tools.